CN100427130C - Medication for treating cardiovascular disease - Google Patents

Medication for treating cardiovascular disease Download PDF

Info

Publication number
CN100427130C
CN100427130C CNB2006101607873A CN200610160787A CN100427130C CN 100427130 C CN100427130 C CN 100427130C CN B2006101607873 A CNB2006101607873 A CN B2006101607873A CN 200610160787 A CN200610160787 A CN 200610160787A CN 100427130 C CN100427130 C CN 100427130C
Authority
CN
China
Prior art keywords
radix
medicine
cardiovascular diseases
semen
angelicae sinensis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006101607873A
Other languages
Chinese (zh)
Other versions
CN1958034A (en
Inventor
李卓伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006101607873A priority Critical patent/CN100427130C/en
Publication of CN1958034A publication Critical patent/CN1958034A/en
Application granted granted Critical
Publication of CN100427130C publication Critical patent/CN100427130C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

A Chinese medicine in the form of pill for treating coronary heart disease, myocardial infarction, myocardial ischemia, arrhythmia and cardiac failure is prepared from 9 Chinese-medicinal materials including astragalus root, Chinese angelica root, red peony root, Chuan-xiong rhizome, etc.

Description

Treatment cardiovascular diseases's medicine
The present invention relates to a kind of cardiovascular diseases's of treatment medicine.Being exactly specifically with the prepared slices of Chinese crude drugs is raw material, the Chinese patent medicine preparation that is used for treating the cardiovascular diseases specially " Yiqi and vein recovery ball " that is prepared from conventional method.
The cardiovascular diseases is the sickness rate height, and is big to patient's hazardness, the class disease that clinical treatment is comparatively thorny.Be first of the human fatal disease.
The object of the present invention is to provide a kind of medicine that the cardiovascular diseases is had better therapeutical effect.
Solution of the present invention is on the basis of Chinese medicine to cardiovascular diseases's pathogenetic understanding and Therapeutic Principle, treatment experience with reference to ancient Chinese medicine doctor, in conjunction with oneself clinical practice for many years, filter out have benefiting QI and nourishing blood, the prepared slices of Chinese crude drugs of function such as warming YANG activating QI, eliminating blood stasis and smoothing collaterals, Yiqi and vein recovery, be prepared from " Yiqi and vein recovery ball " with conventional method.
It is to be made by the medicine of following component that the present invention controls " medicine for the treatment of the cardiovascular diseases ":
Radix Astragali 30-90g Radix Angelicae Sinensis 30-60g 30-90g Radix Ophiopogonis Radix Ilicis Pubescentis 60-120g
Radix Paeoniae Rubra 15-30g Rhizoma Chuanxiong 15-30g Radix Salviae Miltiorrhizae 15-30g Radix Pseudostellariae 60-90g
The Radix Notoginseng 15-30g Lignum Santali Albi 10-20g Radix Rehmanniae 30-90g 10-30g that distinguishes the flavor of
Bulbus Lilii 20-50g Ramulus Cinnamomi 10-30g Fructus Trichosanthis 30-60g Semen Lepidii (Semen Descurainiae) 10-30g
Bulbus Allii Macrostemonis 15-30g Radix Scrophulariae 30-60g Radix Glycyrrhizae 30-60g Herba Taxilli 30-60g
The formula optimization weight proportion scope that the present invention controls " medicine for the treatment of the cardiovascular diseases " is:
Radix Astragali 30-50g Radix Angelicae Sinensis 30-50g 30-50g Radix Ophiopogonis Radix Ilicis Pubescentis 90-120g
Radix Paeoniae Rubra 15-25g Rhizoma Chuanxiong 15-25g Radix Salviae Miltiorrhizae 15-25g Radix Pseudostellariae 60-75g
Radix Notoginseng 15-25g Lignum Santali Albi 10-15g Radix Rehmanniae 30-60g Fructus Schisandrae Chinensis 10-20g
Bulbus Lilii 20-30g Ramulus Cinnamomi 10-20g Fructus Trichosanthis 30-45g Semen Lepidii (Semen Descurainiae) 10-25g
Bulbus Allii Macrostemonis 15-25g Radix Scrophulariae 30-45g Radix Glycyrrhizae 30-45g Herba Taxilli 30-45g
The optimum weight ratio range that the present invention controls " medicine for the treatment of the cardiovascular diseases " is:
Radix Astragali 45g Radix Angelicae Sinensis 45g 45g Radix Ophiopogonis Radix Ilicis Pubescentis 120g
Radix Paeoniae Rubra 20g Rhizoma Chuanxiong 20g Radix Salviae Miltiorrhizae 25g Radix Pseudostellariae 65g
Radix Notoginseng 25g Lignum Santali Albi 15g Radix Rehmanniae 60g Fructus Schisandrae Chinensis 15g
Bulbus Lilii 30g Ramulus Cinnamomi 15g Fructus Trichosanthis 35g Semen Lepidii (Semen Descurainiae) 20g
Bulbus Allii Macrostemonis 20g Radix Scrophulariae 30g Radix Glycyrrhizae 30g Herba Taxilli 35g
Above-mentioned each component decoction pieces is processed with conventional method, both can have been made the present invention's " medicine of treatment cardiovascular diseases ".
The present invention is fully excavating on the empirical basis of traditional treatment, in conjunction with oneself clinical practice for many years, constantly improves forming.Its characteristics are that it is fully at cardiovascular diseases's symptom and prescription.The cardiovascular diseases is many by the heart, the damage of suffering from a deficiency of the kidney, qi depression to blood stasis, and asthenia of qi and blood declines, and Different types of etiopathogenises such as phlegm-damp resistance network cause the breast sun not transport institute extremely.Heart-yang is not transported, and then the yin subjugating yang position is caused blood operation to be obstructed and fallen ill so that numbness knot for a long time.The rule of treatment is worked as with benefiting qi and nourishing blood, activating stagnated YANG, and eliminating blood stasis and smoothing collaterals, Yiqi and vein recovery are main, medicine disease of the present invention conforms to, so can effectively treat coronary heart disease, cardiac muscle stalk, myocardial ischemia, arrhythmia, many clocks such as heart failure cardiovascular diseases.Clinical use effective percentage can reach 97%.

Claims (3)

1. a sharp treatment cardiovascular diseases medicine is characterized in that its active ingredient is made by following materials of weight proportions:
Radix Astragali 30-90g Radix Angelicae Sinensis 30-60g 30-90g Radix Ophiopogonis Radix Ilicis Pubescentis 60-120g
Radix Paeoniae Rubra 15-30g Rhizoma Chuanxiong 15-30g Radix Salviae Miltiorrhizae 15-30g Radix Pseudostellariae 60-90g
Radix Notoginseng 15-30g Lignum Santali Albi 10-20g Radix Rehmanniae 30-90g Fructus Schisandrae Chinensis 10-30g
Bulbus Lilii 20-50g Ramulus Cinnamomi 10-30g Fructus Trichosanthis 30-60g Semen Lepidii (Semen Descurainiae) 10-30g
Bulbus Allii Macrostemonis 15-30g Radix Scrophulariae 30-60g Radix Glycyrrhizae 30-60g Herba Taxilli 30-60g.
2. the described treatment of claim 1 cardiovascular diseases's medicine is characterized in that its active ingredient made by following materials of weight proportions:
Radix Astragali 30-50g Radix Angelicae Sinensis 30-50g 30-50g Radix Ophiopogonis Radix Ilicis Pubescentis 90-120g
Radix Paeoniae Rubra 15-25g Rhizoma Chuanxiong 15-25g Radix Salviae Miltiorrhizae 15-25g Radix Pseudostellariae 60-75g
Radix Notoginseng 15-25g Lignum Santali Albi 10-15g Radix Rehmanniae 30-60g Fructus Schisandrae Chinensis 10-20g
Bulbus Lilii 20-30g Ramulus Cinnamomi 10-20g Fructus Trichosanthis 30-45g Semen Lepidii (Semen Descurainiae) 10-25g
Bulbus Allii Macrostemonis 15-25g Radix Scrophulariae 30-45g Radix Glycyrrhizae 30-45g Herba Taxilli 30-45g.
3. the described treatment of claim 1 cardiovascular diseases's medicine is characterized in that its active ingredient made by following materials of weight proportions:
Radix Astragali 45g Radix Angelicae Sinensis 45g 45g Radix Ophiopogonis Radix Ilicis Pubescentis 120g
Radix Paeoniae Rubra 20g Rhizoma Chuanxiong 20g Radix Salviae Miltiorrhizae 25g Radix Pseudostellariae 65g
Radix Notoginseng 25g Lignum Santali Albi 15g Radix Rehmanniae 60g Fructus Schisandrae Chinensis 15g
Bulbus Lilii 30g Ramulus Cinnamomi 15g Fructus Trichosanthis 35g Semen Lepidii (Semen Descurainiae) 20g
Bulbus Allii Macrostemonis 20g Radix Scrophulariae 30g Radix Glycyrrhizae 30g Herba Taxilli 35g.
CNB2006101607873A 2006-12-04 2006-12-04 Medication for treating cardiovascular disease Expired - Fee Related CN100427130C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101607873A CN100427130C (en) 2006-12-04 2006-12-04 Medication for treating cardiovascular disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101607873A CN100427130C (en) 2006-12-04 2006-12-04 Medication for treating cardiovascular disease

Publications (2)

Publication Number Publication Date
CN1958034A CN1958034A (en) 2007-05-09
CN100427130C true CN100427130C (en) 2008-10-22

Family

ID=38069986

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101607873A Expired - Fee Related CN100427130C (en) 2006-12-04 2006-12-04 Medication for treating cardiovascular disease

Country Status (1)

Country Link
CN (1) CN100427130C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210835A (en) * 2011-06-10 2011-10-12 卢超忠 Traditional Chinese medicine for treating coronary disease

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101496892B (en) * 2008-12-24 2011-05-04 白国君 Oral Chinese patent medicine for treating cardiovascular disease
CN104257849A (en) * 2014-09-20 2015-01-07 济南前程知识产权咨询有限公司 Traditional Chinese medicine for treating cardiovascular diseases
CN104324205A (en) * 2014-11-29 2015-02-04 张晨 Traditional Chinese medicine composition for treating heart diseases
CN104906515A (en) * 2015-06-29 2015-09-16 张保菊 Traditional Chinese medicine composition for treating stenocardia and preparation method thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1356138A (en) * 2001-09-27 2002-07-03 孔金立 Medicine for treating cardiovascular and cerebrovascular diseases of old people

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1356138A (en) * 2001-09-27 2002-07-03 孔金立 Medicine for treating cardiovascular and cerebrovascular diseases of old people

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
冠心病心绞痛临症治验. 李振武.辽宁中医学院学报,第6卷第4期. 2004
冠心病心绞痛临症治验. 李振武.辽宁中医学院学报,第6卷第4期. 2004 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102210835A (en) * 2011-06-10 2011-10-12 卢超忠 Traditional Chinese medicine for treating coronary disease

Also Published As

Publication number Publication date
CN1958034A (en) 2007-05-09

Similar Documents

Publication Publication Date Title
CN102772745B (en) Chinese medicinal preparation for treating cancer and preparation method thereof
CN103341004B (en) Chinese medicine composition for treating delayed menstrual cycle
CN100427130C (en) Medication for treating cardiovascular disease
CN100534513C (en) Chinese medicinal ointment for treating bones and tendons injury pain
CN1320914C (en) Menstruation regulating powder
CN104758484A (en) Traditional Chinese medicine foot-soaking powder for promoting blood circulation and removing blood stasis and preparation and use method of traditional Chinese medicine foot-soaking powder for promoting blood circulation and removing blood stasis
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN102727789B (en) Chinese herbal medicine composition for treating lumbar intervertebral disc herniation
CN101199667A (en) Chinese medicine for treating leukemia, aplastic anemia
CN106581403A (en) Coronary heart disease treating traditional Chinese medicine composition
CN104069453A (en) Traditional Chinese medicine for treating chronic nephritis
CN105853660A (en) Method for synthesizing traditional Chinese medicine for treating diabetes
CN103948875A (en) Medicine for treating hepatitis B and preparation method thereof
CN104547406A (en) Traditional Chinese medicine for treating heart disease
CN1562229A (en) Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B
CN103212024A (en) Chinese medicinal formula for treating dysmenorrhea
CN102397403A (en) Medicine for treating kidney dysfunction
CN101524468A (en) Medicine for treating AIDS
CN100441216C (en) Medication for treating hepatitis B, preparation and taking method
CN101658661A (en) Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis
CN105616860A (en) Traditional Chinese medicine recipe for treating coronary heart diseases
CN105267594A (en) Formula of traditional Chinese medicine for improving sperm activity
CN105125810A (en) Traditional Chinese medicine composition for treating osteonecrosis of femoral head and preparation method thereof
CN105147932B (en) A kind of replenishing kidney and strengthening bone Chinese medicine composition and preparation method thereof
CN104162096A (en) Traditional Chinese medicine for treating melanosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20081022

Termination date: 20100104